Navigation Links
RIEMSER Announces Upcoming Chicago Bone Grafting Workshop
Date:6/24/2009

Pig jaw workshop gives attendees hands-on experience

RESEARCH TRIANGLE PARK, N.C., June 24 /PRNewswire/ -- RIEMSER, a leading manufacturer of bone tissue regeneration and dental implant products, has announced an upcoming advanced bone grafting workshop to be held in Chicago Friday, July 24th from 8:00 am to 4:00 pm. The workshop will provide step-by-step instructions in site preservation, information on bone grafting materials and methods, and hands-on experience with pig jaws. This workshop is designed to help general dentists understand how to integrate bone grafting into their practice.

The course instructor is Dr. Russell Baer, D.D.S. Dr. Baer is currently a Clinical Associate Professor at the University of Chicago where he teaches implant dentistry. He is an active member of the Academy of Osseointegration and the International Congress of Oral Implantology. Dr. Baer has written numerous articles and lectured both nationally and internationally on implant dentistry. His passion of implant dentistry led him to the former Soviet Union, where he founded and serves as the Academic Director of the Chicago Center for Advanced Dentistry, the leading training center for oral implantology and advanced dental techniques, with offices in Moscow, Kiev, Vilnius, Almaty and Mumbai, India.

"This workshop will help dental professionals understand the process of bone grafting and implant procedures," said Rick Patton, Vice President, Sales with RIEMSER. "Participants will experience hands-on training from a leading clinician and will leave with a clear understanding of how to grow their practice through bone grafting procedures."

The course will be held at University Associates in Dentistry, located at 222 N. LaSalle St, Suite 230, Chicago, IL, 60601. Course cost is $695 per person and the deadline to register is Friday, July 17th. Attendees will earn 7 continuing education credits through the Academy of General Dentistry. To register, visit www.RIEMSERdental.com or call 888-237-2767.

About RIEMSER

RIEMSER Inc., with U.S. headquarters in Research Triangle Park, NC, distributes leading products in the field of bone regeneration and dental implants, including Cerasorb(R), EpiGuide(R), Inion GTR(TM) and REVOIS(R). The company is part of RIEMSER Arzneimittel AG, a German pharmaceutical and medical device company that develops, manufactures and markets dental, dermatology, cardiovascular, anti-inflammatory, veterinary, and oncology products. For more information, visit www.RIEMSERdental.com or call 888-237-2767.


'/>"/>
SOURCE RIEMSER Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RIEMSER Announces Upcoming Naperville Bone Grafting Workshop
2. RIEMSER Announces Upcoming Scottsdale Bone Grafting Workshop
3. RIEMSER Announces Upcoming Atlanta Bone Grafting Workshop
4. Bridges to Excellence Announces Five New Physician Recognition Programs With Potential to Save Billions of Health Care Dollars
5. TrinityCare Senior Living Announces Funding Agreement for Fourth Senior Living Facility
6. TriLink BioTechnologies, Inc. Announces Sales and License Agreement With Glen Research Corporation for CleanAmp(TM) Amidites
7. AFIT Accelerated Flight & Instrument Training Announces New Accelerated Flight Training Programs For Cirrus Aircraft Equipped With New Perspective Avionics by Garmin (CSIP)
8. BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
9. Hanger Orthopedic Group, Inc. Announces Second Quarter 2009 Earnings Release Conference Call
10. Derma Sciences Announces First Commercial Sales of BIOGUARD(TM) Barrier Dressings
11. Atlantic Pharmaceuticals, Inc. Announces Completion of Successful Pre-IND Meeting with FDA for Abuse Deterrent Narcotic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 ... an educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd ... approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate ... Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, ... the Board of Directors for CONTACT USA, and former member of the American Association ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic ... manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: